15th International Symposium on Dendritic Cells
June 10–14, 2018 | Aachen, Germany
“Personalized dendritic cell vaccines for ovarian cancer patients”
Lunch Symposium, Lana Kandalaft
Monday, June 11
Immuno-Oncology Summit
August 27–31, 2018 | Boston, USA
“Automation and decentralization of CAR T cell manufacture”
Boro Dropulic, Ph.D., CSO & General Manager, Lentigen Technology, Inc.
Tuesday, August 28, 03:00 p.m. (Find the program here)
“Automation meets cell separation: primary cells for immuno-oncology assays”
Lotta Räty, Product Manager, Cell Separation, Miltenyi Biotec
Wednesday, August 29, 09:30 a.m. (Find the program here)
ECI 2018 – 5th European Congress of Immunology
September 02–05, 2018 | Amsterdam, Netherlands
CAR-TCR Summit
September 04–07, 2018 | Boston, USA
Cell & Gene Therapy Europe
September 11–12, 2018 | London, UK
ELRIG Drug Discovery 2018
October 09–10, 2018 | London, UK
“Automation meets cell separation: primary cells for immuno-oncology assays”
Lotta Räty, Product Manager, Cell Separation, Miltenyi Biotec, Germany
Wednesday, October 10, 12:00–12:30 p.m., Platinum Suite 2
The 9th Asian Cellular Therapy Organization Meeting (ACTO 2018)
October 26–28, 2018 | Chiang Mai, Thailand
Miltenyi Biotec Dinner Symposium “Emerging technologies and clinical advancements in cell therapy”
Friday, October 26, 06:00–07:15 p.m.
Moderator: Yingzi Ge, Miltenyi Biotec, Germany
Presentations:
“Automated manufacturing of chimeric antigen receptor T cells”
Lin Yang, Ph.D., CSO PersonGen BioTherapeutics, China
“CliniMACS Prodigy® Adherent Cell Culture System – An automated, closed, and GMP-compliant platform for complex human cell manufacturing”
Chao Sheng, Ph.D., Product Manager, Regenerative Medicine, Miltenyi Biotec, Germany
60th ASH Annual Meeting & Exposition
December 01–04, 2018 | San Diego, USA
TCT | Transplantation and Cellular Therapy Meetings
(formerly BMT Tandem Meetings)
February 20–24, 2019 | Houston TX, USA
Miltenyi Biotec Product Theater, Friday, February 22, 01:30–02:30 p.m.
“The Latest Advances in Cell Therapy Technologies”
CAR-TCR Summit Europe
February 25–27, 2019 | London, UK
“The Future of CAR-T Cell Manufacturing”
Michael Papadimitrios, Product Manager, Miltenyi Biotec
Tuesday, February 26, 12:45 p.m.
Cell Therapy Manufacturing Asia
February 26–March 01, 2019 | Tokyo, Japan
“T-cell engineering: Driving automation towards commercialization”
Silvio Weber, R&D Industry Business, Miltenyi Biotec
Wednesday, February 27, 12:15 p.m.
3rd Annual Next Gen Immuno-Oncology Congress
March 14–15, 2019 | London, UK
"Validation methods and innovative tools in IO discovery"
Emiliano Melandri, Product Manager, Miltenyi Biotec
Thursday, March 14, 10:05 a.m.
Cellular Therapy 2019
March 22–23, 2019 | Erlangen, Germany
45th Annual Meeting of the European Society for Blood and Marrow Transplantation
March 24–27, 2019 | Frankfurt, Germany
Miltenyi Biotec Industry Symposium, Sunday, March 24, 12:30–02:00 p.m.
“Exploit the benefits of cell therapy”
Kiadis and Miltenyi Biotec Joint Industry Symposium, Sunday, March 24, 04:30–06:00 p.m.
“Innovations in ex vivo T-cell depletion
AACR Annual Meeting 2019
March 29–April 03, 2019 | Atlanta GA, USA
Miltenyi Biotec Spotlight Theater, Monday, April 01, 12:30 p.m. – 01:30 p.m.
“Understand nature’s complexity: Miltenyi Biotec’s new imaging platforms for high-content and 3D imaging”
103rd Annual Meeting of the American Association of Immunologists (AAI) 2019
May 09–13, 2019 | San Diego, USA
ISCT Annual Meeting 2019
May 29–June 1, 2019 | Melbourne, Australia
Miltenyi Biotec Corporate Symposium, Wednesday, May 29, 04:30–06:30 p.m.
“Technology driven progress in cellular therapy”
CliniMACS Prodigy® Workshops, Thursday, May 30 & Friday, May 31, Room 206
Join our live demonstrations of the CliniMACS Prodigy. Learn how genetically modified T cells, or stem cells and their derivatives, can be manufactured in an automated, closed, and scalable system
Immuno-Oncology Summit
August 05-09, 2019 | Boston MA, USA
Training Seminar, Monday/Tuesday, August 05-06
“Introduction to Cancer Immunotherapy Discovery and Development”
Dina Schneider, Ph.D., Associate Director, Translational Research, Lentigen Technology, a Miltenyi Biotec Company
User
